As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the life sciences tools & ...

In a report released today, Luke Sergott from Barclays maintained a Buy rating on 10x Genomics (TXG – Research Report), with a price target of ...

EDT Cathie Wood’s ARK Investment buys 191.5K shares of 10x Genomics (TXG) todayStay Ahead of the Market: Discover outperforming stocks ...

Torex Gold Resources (TSE:TXG – Free Report) had its target price increased by Raymond James from C$34.00 to C$47.00 in a ...

Detailed price information for Torex Gold Resources Inc (TXG-T) from The Globe and Mail including charting and trades.

I assign TXG a buy rating with a 1-year price target of $12.7 per share, projecting an 18% upside YoY. TXG's new lower-cost Chromium offerings could drive volume growth and increased adoption ...

What Happened? A number of stocks jumped in the afternoon session after markets rallied sharply on news that President Trump ...

Torex Gold Resources (TSE:TXG – Get Free Report) had its target price boosted by analysts at Royal Bank of Canada from C$44.00 to C$45.00 in a research report issued to clients and investors on Friday ...

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa ...

While Donald Trump spared pharma companies from his tariff announcement last week, he revealed yesterday plans to announce ...

Torex Gold Resources ( ($TSE:TXG) ) just unveiled an announcement. Torex Gold Resources reported its Q1 2025 production results, achieving ...